Numerous authorities have issued warnings of the toxic side effects of birth control tablets Yaz and Yasmin. In 2011, both the United States Food and Drug Administration (FDA) and the British Medical Journal published studies linking the synthetic form of progestin in Yaz with a significantly increased risk of blood clots and resultant deep vein thrombosis (DVT) and pulmonary embolism.
The Institute for Safe Medicine Practice’s May 31, 2012, QuarterWatch report listed Yaz and Yasmin as the drugs with the second highest number of complications reported to the FDA in 2011. A few months later, in October 2012, the American College of Obstetricians and Gynecologists (ACOG) warned of the increased risk of blood clots from drospirenone, the synthetic form of progestin used in Yaz and Yasmin.
Yaz and Yasmin lawsuits brought against Bayer alleged that Bayer failed to adequately warn consumers of the dangerous risks of Yaz and Yasmin. So far, these legal actions have resulted in payments of approximately $1.75 billion by Bayer to women injured by Yaz and Yasmin. Bayer continues to settle additional Yaz and Yasmin lawsuits.